Clinical trial
Bioequivalence of Ciprofloxacin 0.3%: a Randomized, Multicenter, Parallel, Comparative Study on the Safety and Efficacy of Ciprofloxacin 0.3% in a Standard Solution or Foam Solution, in Patients With Acute External Otitis.
NCT00872209 is registered in ClinicalTrials.gov with Otic Pharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bioequivalence of Ciprofloxacin 0.3%: a Randomized, Multicenter, Parallel, Comparative Study on the Safety and Efficacy of Ciprofloxacin 0.3% in a Standard Solution or Foam Solution, in Patients With Acute External Otitis.
- Lead sponsor
- Otic Pharma
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- May 31, 2009
- Completion date
- November 30, 2009
- Enrollment
- 100 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.